In-Depth Report Forecasts Immunosuppressants Market Growth to $48.88 Billion by 2028 at 13.2% CAGR, Driven by Organ Transplants

The new report published by The Business Research Company, titled "Immunosuppressants Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the immunosuppressants market size has grown rapidly in recent years. It will grow from $25.94 billion in 2023 to $29.72 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The immunosuppressants market size is expected to see rapid growth in the next few years. It will grow to $48.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3467&type=smp

Organ Transplants Fueling Growth In The Immunosuppressant Market
The surge in organ transplant procedures such as kidney and liver transplants due to the rise in incidences of organ failure is the major factor driving the immunosuppressant market's growth. For instance, according to the American Kidney Fund, a US-based health organization, on the national transplant waiting list in June 2022, there will be more than 106,000 people, of whom 92,000 (or 87%) are waiting for a kidney transplant in the US. The increasing number of cases of organ transplants and incidences of organ failure in patients is therefore expected to drive immunosuppressants market growth.

Transforming Drug Dosing And Clinical Decision-Making
Phenotypic personalized medicine or PPM or a hybrid of artificial intelligence and physician intervention is a new approach to overcoming the issues with immunosuppressants. For instance, tacrolimus is the most widely used immunosuppressant for patients who are undergoing organ transplantation. When the patient is in the hospital, Tacrolimus immunosuppressant levels must be checked regularly and changed frequently. A PPM approach that is based on a computational platform is used to overcome this concern. The inputs from the computational platform-based PPM approach include the past response of the patient to the dose of the drug and other drugs that are being taken, as well as current data on the liver and kidney. Using PPM, the physician can identify the optimal drug and dose combination from various possibilities. Therefore, it is believed that artificial intelligence is leading the way to not only more personalized and effective drug dosing but also enhancing physicians' decision-making capabilities by providing clinical data rather than predicted responses.

The immunosuppressants market covered in this report is segmented -
1) By Drug Class: Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes
2) By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=3467&type=discount

Major companies operating in the immunosuppressants market report are Pfizer Inc., Johnson & Johnson Services Inc., BASF SE, F Hoffmann La Roche Ltd., AbbVie Inc., Allergan plc, Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., GlaxoSmithKline plc, Covestro AG, Mylan Laboratories Inc., Teva Pharmaceuticals USA Inc., Astellas Pharma Inc., Sandoz Inc., Aurobindo Pharma Limited, Hikma Pharmaceuticals plc, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Fresenius Kabi USA, Lupin Pharmaceuticals Inc., Strides Pharma Inc., Accord Healthcare Ltd., RPG Life Sciences Limited, Genzyme Transgenics Corp., Akriti Pharmaceuticals Pvt. Ltd., SEBELA PHARMACEUTICALS Inc., Healthy Life Pharma Private Limited, Apotex Inc

Contents of the report:
1. Executive Summary
2. Immunosuppressants Market Report Structure
3. Immunosuppressants Market Trends And Strategies
4. Immunosuppressants Market - Macro Economic Scenario
5. Immunosuppressants Market Size And Growth
…..
27. Immunosuppressants Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.